INDEX PHARMACEUTICALS
InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer.
INDEX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2000-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.indexpharma.com
Total Employee:
11+
Status:
Active
Contact:
46 8 50 88 47 30
Email Addresses:
[email protected]
Total Funding:
31.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vinnova
Vinnova investment in Grant - InDex Pharmaceuticals
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - InDex Pharmaceuticals
Vinnova
Vinnova investment in Grant - InDex Pharmaceuticals
Industrifonden
Industrifonden investment in Venture Round - InDex Pharmaceuticals
Neomed Management
Neomed Management investment in Venture Round - InDex Pharmaceuticals
SEB Venture Capital
SEB Venture Capital investment in Venture Round - InDex Pharmaceuticals
SEB Venture Capital
SEB Venture Capital investment in Private Equity Round - InDex Pharmaceuticals
Industrifonden
Industrifonden investment in Private Equity Round - InDex Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.indexpharma.com Semrush global rank: 6.08 M Semrush visits lastest month: 1.34 K
- Host name: 104.21.27.139
- IP address: 104.21.27.139
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InDex Pharmaceuticals"
InDex Pharmaceuticals strengthens the organization with Eva
May 2, 2022 โ InDex Pharmaceuticals Holding AB (publ) today announced that the company has appointed Eva Arlander as Chief Development Officer. Eva will also be part of the โฆSee details»
InDex Pharmaceuticals AB - LinkedIn
Indexpharma.com 59 Like Comment Share InDex Pharmaceuticals AB 1,474 followers 7mo Report this post Today, InDex Pharmaceuticals Holding AB published the Annual Report for โฆSee details»
InDex Pharmaceuticals provides a company update โ Flerie
Apr 8, 2024 E-mail: [email protected]. Johan Giléus, CFO and deputy CEO Phone: +46 8 122 038 50 E-mail: [email protected]. Publication The โฆSee details»
About Us โ Index Pharmaceuticals
Founded in 1998 by the forward-thinking Mr. Amish Shah, Index Pharma LLP emerged from his seven-year immersion in the pharmaceutical industry, where he cultivated relationships and established a lasting legacy.See details»
InDex Pharmaceuticals - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for InDex Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report โฆ
Request to [email protected], or by mail to InDex Pharmaceuticals Holding AB (publ), Berzelius väg 13, 171 65 Solna, Sweden. For more information: Jenny Sundqvist, CEO โฆSee details»
Index Pharmaceuticals: InDex Pharmaceuticals Holding AB (publ ...
The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected],or by mail to InDex Pharmaceuticals Holding AB โฆSee details»
InDex Pharmaceuticals - Craft
Aug 13, 2024 InDex Pharmaceuticals has 5 employees at their 1 location and kr97.51 m in annual revenue in FY 2023. See insights on InDex Pharmaceuticals including office locations, โฆSee details»
InDex Pharmaceuticals strengthens the clinical development โฆ
Aug 23, 2021 E-mail: [email protected]. Publication The information was submitted for publication through the agency of the contact person set out above at 08:00 CET โฆSee details»
Press releases โ InDex Pharmaceuticals
InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals ABโs wholly owned subsidiary โฆSee details»
InDex Pharmaceuticals strengthens the organization with Eva โฆ
May 2, 2022 InDex is based in Stockholm, Sweden. The companyโs shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Redeye AB with email address โฆSee details»
InDex Pharmaceuticals Holding AB (publ) interim report January ...
Nov 23, 2022 The Board has appointed Jenny Sundqvist as new CEOSee details»
Index Pharmaceuticals: InDex Pharmaceuticals enters agreement โฆ
Mar 30, 2021 E-mail: [email protected]. Publication The information was submitted for publication through the agency of the contact person set out above at 8:00 CET โฆSee details»
InDex Pharmaceuticals provides an update on companyโs future
Feb 26, 2024 E-mail: [email protected]. Johan Giléus, CFO and deputy CEO Phone: +46 8 122 038 50 E-mail: [email protected]. Publication The โฆSee details»
InDex Pharmaceuticals enters agreement with Parexel Biotech for โฆ
STOCKHOLM, March 30, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an agreement for services with global clinical โฆSee details»
InDex Pharmaceuticals enters agreement with Parexel Biotech for โฆ
Mar 30, 2021 E-mail: [email protected] Publication The information was submitted for publication through the agency of the contact person set out above at 8:00 CET โฆSee details»
Index Pharmaceuticals
Index Pharma has facilitated more than 15 audits for our customers and suppliers. Our 3rd party audits foster trust, support customers and suppliers, facilitating seamless business in India.See details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual ... - Flerie
Apr 8, 2022 The Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected], or by mail to InDex โฆSee details»
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report โฆ
Apr 23, 2021 The printed Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to [email protected], or by mail to InDex โฆSee details»